DongKoo Bio & Pharma Co., Ltd. (KOSDAQ: 006620)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,040.00
-20.00 (-0.40%)
Jan 22, 2025, 3:00 PM KST

DongKoo Bio & Pharma Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2017 2016 - 2015
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '17 2016 - 2015
Net Income
15,33711,8126,6149,3279,14010,943
Upgrade
Depreciation & Amortization
6,6846,0285,6325,0544,5062,207
Upgrade
Loss (Gain) From Sale of Assets
-5.980-123.891.3381.62-0.33
Upgrade
Asset Writedown & Restructuring Costs
300--0--
Upgrade
Loss (Gain) From Sale of Investments
-8,701-2,0778,869-1,090-1,985-68.17
Upgrade
Loss (Gain) on Equity Investments
3,977660.61-118.281,733-726.96528.35
Upgrade
Stock-Based Compensation
257.97224.51---243.63
Upgrade
Provision & Write-off of Bad Debts
-120.34-52.8240.44241.761,370417.54
Upgrade
Other Operating Activities
6,1961,697331.91638.041,7441,690
Upgrade
Change in Accounts Receivable
-1,443-1,333-2,8611,4311,532-5,771
Upgrade
Change in Inventory
-2,750-12,838-6,686-1,897-7,192-1,561
Upgrade
Change in Accounts Payable
-4,825-3,0932,7152,399-2,040969.88
Upgrade
Change in Other Net Operating Assets
4,0722,5582,40465.11,058-92.24
Upgrade
Operating Cash Flow
18,9783,58516,81917,9037,4899,507
Upgrade
Operating Cash Flow Growth
57.00%-78.68%-6.05%139.06%-21.23%-24.47%
Upgrade
Capital Expenditures
-26,134-13,845-4,978-4,266-5,268-810.51
Upgrade
Sale of Property, Plant & Equipment
60.66300.4411.97--
Upgrade
Sale (Purchase) of Intangibles
-3,835-2,034-6,098-1,137-192.72-8.48
Upgrade
Investment in Securities
-4,97711,851-16,2876,202-6,072-971.17
Upgrade
Other Investing Activities
523.28-10639-366.43-1,05916.09
Upgrade
Investing Cash Flow
-35,955-5,133-27,014463.93-12,564-1,774
Upgrade
Short-Term Debt Issued
-7,50015,00070.7510,0006,290
Upgrade
Long-Term Debt Issued
-1,447----
Upgrade
Total Debt Issued
45,2188,94715,00070.7510,0006,290
Upgrade
Short-Term Debt Repaid
-----6,883-9,230
Upgrade
Long-Term Debt Repaid
--1,126-5,966-742.12-2,536-1,215
Upgrade
Total Debt Repaid
-9,292-1,126-5,966-742.12-9,419-10,445
Upgrade
Net Debt Issued (Repaid)
35,9267,8219,034-671.37581.47-4,155
Upgrade
Issuance of Common Stock
-----1,402
Upgrade
Repurchase of Common Stock
-3,079-79.9-2,995-1,998--
Upgrade
Dividends Paid
-3,313-3,038-2,804-942.94-942.92-
Upgrade
Other Financing Activities
1,54549-50-76.10-
Upgrade
Financing Cash Flow
31,0794,7523,185-3,688-361.45-2,753
Upgrade
Foreign Exchange Rate Adjustments
-85.85-4.74-33.91-2.27-23.18-0
Upgrade
Miscellaneous Cash Flow Adjustments
--0-0-00
Upgrade
Net Cash Flow
14,0163,199-7,04314,676-5,4604,980
Upgrade
Free Cash Flow
-7,156-10,26011,84113,6372,2218,696
Upgrade
Free Cash Flow Growth
---13.17%514.06%-74.46%44.13%
Upgrade
Free Cash Flow Margin
-2.82%-4.76%6.07%8.79%1.60%8.60%
Upgrade
Free Cash Flow Per Share
-260.75-371.44426.63482.5778.50387.18
Upgrade
Cash Interest Paid
2,4461,672902.19362.76401.35484.24
Upgrade
Cash Income Tax Paid
3,5094,1043,0761,392730.991,254
Upgrade
Levered Free Cash Flow
-12,064-15,354-140.4310,027-4,462
Upgrade
Unlevered Free Cash Flow
-10,501-14,254509.1410,286-4,821
Upgrade
Change in Net Working Capital
-1,29213,6854,571-5,549-5,149
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.